Lupin Atlantis Holdings SA signed an asset purchase agreement to acquire a selection of established products in Europe and Canada from Sanofi (ENXTPA:SAN) for ?18 million on December 22, 2023. The acquisition cost comprises of ?10 million upfront, along with potential additional payments of up to ?8 million based on future sales milestones. As part of this agreement, Lupin will take ownership of AARANE in Germany and NALCROM in Canada and the Netherlands. The turnover generated by these brands in the markets totaled approximately ?6.00887 million for the year ending March 31, 2023. The completion of this acquisition is subject to approval from Canada's Foreign Direct Investment Bureau and is expected to finalize by the first quarter of 2024.

Lupin Atlantis Holdings SA completed the acquisition of selection of established products in Europe and Canada from Sanofi (ENXTPA:SAN) on June 5, 2024.